Krishna Institute of Medical Sciences has published the audio recording of its investor conference call for Q1 FY27, providing stakeholders access to management commentary on the quarter's performance. The call was held on August 7, 2025, and the recording is now available on the company’s official website under the disclosures section for analysts' calls. This move ensures transparency and allows investors to review the detailed discussion regarding financial results and operational updates.

The filing was submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in compliance with regulatory norms. Specifically, the disclosure aligns with Regulation 30 and Regulation 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These regulations mandate timely dissemination of material information to ensure fair access to data for all market participants.

Disciplinary Compliance

Krishna Institute of Medical Sciences Limited emphasized its adherence to listing obligations by formally notifying the exchanges. The audio file can be accessed via the company’s investor relations portal at https://www.kimshospitals.com/investors , specifically under the path: Disclosures under Regulation 46 > Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 26-27.

Corporate Governance

The communication was signed by Nagajayanthi J. R., who serves as the Company Secretary and Compliance Officer for Krishna Institute of Medical Sciences Limited. Her signature authenticates the disclosure, confirming that the information provided is accurate and complete as per the company’s records. The filing underscores the organization’s commitment to maintaining robust corporate governance standards and regulatory compliance.

Investors are advised to review the recording alongside other financial documents released during the quarter to gain a comprehensive understanding of the company’s strategic direction and financial health. The availability of such recordings supports informed decision-making by providing direct insights from management rather than relying solely on summarized reports.

Krishna Institute of Medical Sciences has outlined its capital allocation priorities, signalling a growth-oriented approach by directing the bulk of future cash flows toward greenfield expansion rather than debt reduction. The company's strategy reflects a deliberate choice to invest in capacity building while maintaining a defined leverage threshold.

Capital Allocation Strategy

According to the concall update, KIMS plans to deploy most of its future cash flows into greenfield expansion initiatives. Rather than aggressively paying down existing debt, the company intends to sustain a measured level of leverage to fund new facility development.

Leverage Target

As part of this capital strategy, KIMS is aiming for a debt-to-equity ratio of around 2.5:1. This target indicates the company's comfort with maintaining a structured level of debt on its books as it pursues expansion, rather than pursuing a rapid deleveraging path.

The concall update did not provide additional details regarding specific greenfield project locations, timelines, or associated capital expenditure figures. The strategy underscores KIMS's focus on scaling its healthcare infrastructure through new facility development as its primary near-term objective.